The ROE as of November 2025 (TTM) for Gene Biotherapeutics, Inc. (CRXM) is 12.69%

According to Gene Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 12.69%. This represents a change of 355.48% compared to the average of 2.79% of the last 4 quarters.

Gene Biotherapeutics, Inc. (CRXM) Historical ROE (quarterly & annually)

How has CRXM ROE performed in the past?

The mean historical ROE of Gene Biotherapeutics, Inc. over the last ten years is -44.12%. The current 12.69% ROE has changed -128.75% with respect to the historical average. Over the past ten years (40 quarters), CRXM's ROE was at its highest in in the September 2014 quarter at 422.03%. The ROE was at its lowest in in the December 2013 quarter at -233.32%.

Gene Biotherapeutics, Inc. (CRXM) ROE by Quarter and Year

Discovering the peaks and valleys of Gene Biotherapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gene Biotherapeutics, Inc. (CRXM) Average ROE

How has CRXM ROE performed in the past?

The current ROE of Gene Biotherapeutics, Inc. (CRXM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Gene Biotherapeutics, Inc. (CRXM) ROE vs. Peers

How is CRXM’s ROE compared to its peers?

Gene Biotherapeutics, Inc.’s ROE is less than Gelesis Holdings, Inc. (31.43%), less than NeonMind Biosciences Inc. (366.65%), less than E-Qure Corp. (175.41%), less than GeneThera, Inc. (12.75%), less than American CryoStem Corporation (253.85%), less than Capha Pharmaceuticals Inc. (9.55%), less than Acacia Diversified Holdings, Inc. (138.70%), less than Generex Biotechnology Corporation (216.76%), less than Navidea Biopharmaceuticals, Inc. (355.34%), greater than WPD Pharmaceuticals Inc. (-4.39%),

Build a custom stock screener for Gene Biotherapeutics, Inc. (CRXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gene Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gene Biotherapeutics, Inc. (CRXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gene Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.